Monitor Ventures Inc
XTSX:MVI.H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Monitor Ventures Inc
XTSX:MVI.H
|
CA |
|
T
|
Tokyo Kisen Co Ltd
TSE:9193
|
JP |
|
F
|
Fast Accounting Co Ltd
TSE:5588
|
JP |
|
Travel + Leisure Co
NYSE:TNL
|
US |
|
A
|
Alimak Group AB (publ)
LSE:0R8W
|
SE |
|
S
|
Suzhou K-Hiragawa Electronic Technology Co Ltd
SSE:603052
|
CN |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
Balance Sheet
Balance Sheet Decomposition
Monitor Ventures Inc
Monitor Ventures Inc
Balance Sheet
Monitor Ventures Inc
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
4
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
4
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
6
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
7
N/A
|
6
-22%
|
4
-35%
|
1
-87%
|
0
-54%
|
0
-22%
|
0
-17%
|
0
-33%
|
0
-60%
|
0
N/A
|
0
N/A
|
0
-91%
|
0
+67%
|
0
+367%
|
0
+94%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
5
|
3
|
3
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
6
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+63%
|
1
+17%
|
2
+52%
|
6
+144%
|
3
-43%
|
3
-6%
|
1
-62%
|
1
-19%
|
1
N/A
|
1
-19%
|
1
+5%
|
1
+5%
|
1
+4%
|
1
-7%
|
|
| Equity | ||||||||||||||||
| Common Stock |
14
|
17
|
24
|
30
|
30
|
30
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
|
| Retained Earnings |
7
|
13
|
22
|
32
|
36
|
33
|
33
|
32
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
5
-31%
|
2
-49%
|
2
N/A
|
5
-202%
|
3
+44%
|
3
+5%
|
1
+63%
|
1
+14%
|
1
-4%
|
1
+20%
|
1
-7%
|
1
-5%
|
1
-4%
|
1
+8%
|
|
| Total Liabilities & Equity |
7
N/A
|
6
-22%
|
4
-35%
|
1
-87%
|
0
-54%
|
0
-22%
|
0
-17%
|
0
-33%
|
0
-60%
|
0
N/A
|
0
N/A
|
0
-91%
|
0
+67%
|
0
+367%
|
0
+94%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
|